A cDNA sequencing project was initiated to characterize gene expression in human bone marrow and develop strategies to isolate novel genes. Forty-eight random cDNAs from total human bone marrow were subjected to single-pass DNA sequence analysis to determine a limited complexity of mRNAs expressed in the bone marrow. Overall, 8 cDNAs (17%) showed no sim to known sequences. Information from DNA sequence analysis was used to develop a differential prescreen to subtract unwanted cDNAs and to enrich for unknown cDNAs. Forty-eight cDNAs that were negative with a complex probe were subject to single-pass DNA sequence determination. Of these prescreened cDNAs, the number of unknown sequences increased to 23 (48%). Unknown cDNAs were also characterized by RNA expression analysis using 25 different human leukemic cell lines. Of 13 unknown cDNAs tested, 10 were expressed in all cell types tested and 3 revealed a hematopoietic lineage-restricted expression pattern. Interiy, while a total of only 96 bone marrow cDNAs were sequenced, 31 of these cDNAs represent sequences from unknown genes and 12 showed ificant similarities to sequences in the data bases. One cDNA revealed a si nt similit to a serine/threonine-protein kinase at the amino acid level (56% Identity for 123 amino acids) and may represent a previously unknown kinase. Differential screening techniques coupled with single-pass cDNA sequence analysis may prove to be a powerful and simple technique to eamine developmental gene expression.
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Large-scale cDNA sequencing is an important part of the Human Genome Project. The sequence identification of all expressed cDNAs will benefit a wide variety of research, including physical mapping, gene structure analysis, and the identification of the genetic basis for many diseases (1, 2) . Of the approximately 100,000 human genes, an estimated 29,000 human sequences are present in the data bases. To isolate every human gene, it will be necessary to construct cDNA libraries from a variety of tissues and developmental states. In addition, the use of sophisticated cDNA library construction and library screening techniques will also be necessary to decrease cDNA sequence redundancy and increase the probability of isolating rare cell-specific cDNAs. It is likely that each tissue source will pose unique problems before all human cDNAs are isolated. Thus combinations of cellular enrichment techniques, subtracted or normalized libraries, and differential screening will be necessary to isolate rare human mRNAs. Recent human cDNA sequencing projects have been successful at isolating genes expressed in the brain (1, 3) , testis (4), T cells (5) , and retinal epithelium (6 "To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. supercompetent XL1-Blue cells (Stratagene) and titrated to a density of 500 plaques per plate. Individual plaques were picked and tested for inserts by PCR using M13 (IacZ) primers (BV40, 5'-ACGTTGTAAAACGACGGCCAGT-3'; BV41, 5'-GAAACAGCTATGACCATGATTA-3').
Differential Hybridization. For differential screens, 48 BM cDNAs were sequenced and subject to DNA sequence analysis. Twenty-seven of these identified BM cDNAs were chosen to represent known human sequences and unwanted cDNAs such as globin. Two probes were prepared and mixed in the final hybridization. The first probe consisted of gelpurified PCR products of the 27 BM cDNAs with known sequences, pooled and labeled by random priming. The second probe was synthesized by using 2.4 Mg of HeLa cell poly(A)+ RNA and avian myeloblastosis virus reverse transcriptase (Molecular Genetics) to a specific activity of 1.5 x 107 cpm/,ug, and the entire cDNA reaction mixture was added to the hybridization mixture with the first BM probe. Differential hybridizations, of 104 M13 phage plated to a density of -500 plaque-forming units per plate, were performed in 5x SSPE/Sx Denhardt's solution containing salmon sperm DNA at 100 ,g/ml, 10%o dextran sulfate, and 0.1% SDS for 16 hr at 580C. Filters were washed once in 2x SSC/0.1% SDS at 250C and three times in 0.2x SSC/0.1% SDS at 650C. (lx SSPE = 150 mM NaCl/10 mM sodium phosphate, pH 7.4/1 mM EDTA; lx Denhardt's solution = 0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinylpyrrolidone; lx SSC = 150 mM NaCl/15 mM sodium citrate, pH 7.0.) Plates contained 5-10%o background nonrecombinants.
RNA Gel Blot Hybridization. Total RNA was isolated from cell lines (7) and 20 ug was electrophoresed on formaldehyde/1% agarose gels. RNA was transferred to nitrocellulose and probed with gel-purified PCR products labeled by random priming. Probes were added to hybridization mixtures containing 50% deionized formamide, 5 x SSC, lx Denhardt's solution, 50 mM sodium phosphate at pH 7.0, and salmon sperm DNA at 0.25 mg/ml and hybridized for 12-16 hr at 420C. Blots were washed in 2x SSC/0.1% SDS at room temperature for 30 min and in 2x SSC/O.1% SDS at 600C for 30-60 min. Cell lines were kind gifts from the following sources: KG1 (8, 9) and M07E, provided by D. Golde (Sloan-Kettering); AF10, provided by A. Saxon [University of California, Los Angeles (UCLA)]; Jurkat (10), provided by W. Clark (UCLA); CCRF-CEM (11), provided by C. Uittenbogaart (UCLA); PLB 985 (12), provided by S. Smale (UCLA); and BV173 (13) and IMR 5, provided by A. Van Herle (UCLA). Also used were ALL-1 (14) and HEL (15) .
cDNA Sequence Determination and Data Base Analysis. For single-run DNA sequence determination, M13 DNA was prepared using a PEG miniprep procedure starting with 1.0 ml of infected culture. Sequence determination was performed by using Taq DNA polymerase, M13 fluorescent primers (Applied Biosystems), and the Applied Biosystems catalyst. Reactions were run on the Applied Biosystems 373 automated DNA sequencer. Approximately 400 bases were compared with nonredundant European Molecular Biology Laboratory and GenBank data bases (version 73), using BLAST (16) . Sequences were also translated and used to search the protein data bases (Protein Identification Resource), using the BLASTX sequence analysis program. DNA sequences that were determined to be unknowns from the BLAST analysis were subjected to further analysis using the FASTA program (17) . In addition, all unknown sequences were sent by electronic mail to GRAIL (Gene Recognition and Analysis Internet Link) (18) . Predicted exons were translated and further protein analysis was performed by using the FASTA program.
RESULTS
Partial DNA Sequence Analysis of BM cDNAs. Random shotgun DNA sequencing of cDNAs is straightforward and is based upon the assumption that if the sequence was prepared from mRNA, it represents an expressed gene. The drawbacks of limited shotgun sequencing are the loss of expression information, possible sequencing of noncoding regions, and the generation of sequence data from different regions of the same transcript. We are beginning a cDNA sequencing project using cDNAs isolated from human BM. Since we are interested in isolating rare mRNAs that are expressed by the developing hematopoietic system, we are evaluating combinations of cDNA library prescreening coupled with rapid methods for expression analysis. Forty-eight BM cDNAs were subject to single-pass DNA sequence determination. Eight (17%) of these represented cDNA sequences not found in searching the GenBank data bases, using the BLAST sequence analysis program ( Table 1 ). The major mRNA expressed in total BM was determined to be globin. Globin was found to be present in 23% of the cDNAs sequenced. Globin mRNA has been measured at 3% of murine reticulocyte RNA, and up to 22,600 copies of globin mRNA have been found per cell (19) . Our result may be higher than expected given a limited cDNA sample size. Other known mRNAs observed in the random library include mitochondrial genes, ribosomal sequences, and repeats. Additional abundant sequences were observed that may be unique to BM-derived cDNAs. In addition to globin, these abundant BM mRNAs include eosinophil basic protein and immunoglobulins.
Initial cDNA sequencing and analysis of the total BM library revealed problems associated with large-scale sequencing, such as the repetitive sequencing of common "housekeeping" and other abundant mRNAs. To eliminate these abundant unwanted sequences and increase the number of rare, cell-specific, and possibly unknown sequences, a differential screening strategy was tested. A complex probe consisting of two cDNA mixtures was designed to eliminate abundant sequences. This probe contained labeled cDNAs from the known BM sequences (Table 1 ) and labeled cDNA Once BLAST analysis failed to reveal significant similarities between cDNA sequences and sequences in the data bases, the unknown sequences were then subject to further analysis, including GRAIL and FASTA. Twenty-two sequences from unknown cDNAs were sent to the GRAIL system for putative exon prediction. The GRAIL system uses a multiple sensor neural network to identify protein-coding regions of at least 100 bases and has proven to accurately predict exons 89%o of the time (18) . Eight of the 22 cDNAs examined by GRAIL contained potential exons (Table 2) . One explanation why many of the sequences failed to contain predicted protein-coding regions may be that these sequences are derived from noncoding regions. These contributions could be from 3' or 5' untranslated regions or from incompletely spliced poly(A)+ RNAs, which are frequently observed in BM cDNA libraries. The quality of the exon predictions according to GRAIL varied equally from "excellent" to "good." Since protein data base searches are more sensitive than nucleic acid searches, the translated protein sequences of predicted exons following GRAIL analysis were examined for similarities to known proteins by using the FASTA program. While this exon analysis regime failed to find a significant similarity to a known sequence, one cDNA exhibited short and multiple similarities to Na/K-ATPases (data not shown). Overall, the most important criterion to prioritize unknown cDNAs for further analysis is a significant BLASTX tQuality equals the GRAIL systems interpretation of raw data, taking-into account strand, probability, frame, and ORF data.
(protein) similarity. However, the presence of predicted exons and multiple weak similarities to known genes can also be used to prioritize unknown cDNAs for -further RNA expression analysis employing Northern blots.
RNA Expression Anaysis of Unknown cDNAs. Following DNA sequence analysis, unknown cDNAs were tested for expression against a panel of human leukemic cell lines. These cell lines were chosen to represent a variety of different hematopoietic cell types and differentiation states, including multipotent cell lines. First, PCR products of cDNAs were labeled and tested on RNA blots, using a limited number of cell lines. This preliminary screen was used to quickly assay whether the expression was restricted to a cell type or was ubiquitously expressed among all cell lines tested. Following this preliminary screen, the strategy was to increase the number of cell lines tested and probe with cDNAs that exhibited restricted or no expression. Of 13 unknown cDNAs tested, 10 were expressed in all cell lines tested and 3 revealed a restricted expression pattern (Fig. 1) . In addition, one cDNA, PSBM6, exhibited two transcripts on RNA blots. Further analysis of the 3 cDNAs with restricted expression revealed major but not exclusive expression in early myeloid cell lines. This may reflect the predominance of myeloid cells over erythroid and lymphoid cells in nucleated BM populations (20) . One caveat concerning using mRNA from continuous cell lines is that aberrant gene expression may limit their value to assign gene expression to defined cell types. As a consequence, it becomes necessary to include multiple cell lines representing the same lineage or state of differentiation on RNA blots. However, the ease in growing large quantities ofthese cells to isolate mRNA to use in RNA blots makes these cell lines ideal for an initial prescreen. To characterize lineage-specific expression further, it will be necessary to use panels of normal human BM and peripheral blood cells and to enrich for specific cell types either by sorting or by selective culture conditions. In addition, further analysis will include complete DNA sequence determination and chromosomal mapping. DNA (Fig. 2) .
Of the 16 cDNAs that exhibited significant similarities to known genes, one cDNA was of particular interest. PSBM6 was observed to be similar to protein kinase sequences on both the nucleic acid and protein level. In addition, multiple significant similarities to other kinases were present throughout the sequence. The highest similarity was a 56%/123 amino acid identity to human p78 (Fig. 2) . This kinase is an unpublished data base entry described as a 78-kDa marker lost in a chemically induced transplantable carcinoma and related to serine/threonine-protein kinases. Therefore this cDNA probably encodes a nonreceptor kinase that may catalyze protein phosphorylation in response to second messengers.
SUMMARY AND CONCLUSIONS
cDNA Analysis. Recently large-scale cDNA sequencing projects have contributed thousands of short (>150-to 500-bp) cDNA sequences to the data bases (1, 3, 22 BLASTN and BLASTX results of unknown BM cDNAs with similarities to known genes with a P(N) c 0.01. The P(N) value represents the probability of a score occurring by chance, given the size of the sequence searched and the size of the data base. The yeast is Saccharomyces cerevisiae; TNF, tumor necrosis factor; S. mansoni, Schistosoma mansoni. 
